☆ 4.6 Article

One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis

BRITISH JOURNAL OF DERMATOLOGY (2014)

Get Full Text
Add to Collection

Journal

BRITISH JOURNAL OF DERMATOLOGY
Volume 170, Issue 2, Pages 435-444

Publisher

WILEY
DOI: 10.1111/bjd.12643

Keywords

-

Categories

Dermatology

Funding

  1. Janssen Pharmaceutica NV
  2. Janssen

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.